Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-06-08 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −21,250 678,750
2020-06-03 DOBMEIER ERIC Director Option exercise +5,000 $6.32 $32K 5,000
2020-06-03 DOBMEIER ERIC Director Sale −5,000 $39.79 $199K 0
2020-06-03 DOBMEIER ERIC Director Option exercise · Stock Option (Right to Buy) −5,000 65,000
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 2,604
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 5,208
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise +1,562 $7.27 $11K 6,770
2020-06-03 BENZENO SHARON Chief Business Development Off Sale −6,770 $40.00 $271K 0
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 43,271
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 72,917
2020-06-03 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,562 48,438
2020-05-26 Taylor Stacy L SVP and General Counsel Option exercise +1,109 $7.80 $9K 2,409
2020-05-26 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 4,180
2020-05-26 Taylor Stacy L SVP and General Counsel Sale −2,880 $42.00 $121K 1,300
2020-05-26 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,109 40,581
2020-05-26 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,771 38,959
2020-05-26 BENZENO SHARON Chief Business Development Off Option exercise +416 $6.32 $3K 416
2020-05-26 BENZENO SHARON Chief Business Development Off Sale −416 $42.00 $17K 0
2020-05-26 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −416 834
2020-05-21 ROBINS CHAD M CEO and Chairman Option exercise +50,000 $0.33 $17K 1,928,180

Page 103 of 120 · 2,386 trades